Stem Cell Manufacturing Market: Trends, Opportunities and Competitive Analysis [2023-2028]
2 – 3 business days by ordering today
Stem Cell Manufacturing Market Trends and Forecast
The future of the global stem cell manufacturing market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes. The global stem cell manufacturing market is expected to reach an estimated $6.3 billion by 2028 with a CAGR of 9.7% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases and growing consumer awareness towards therapeutic efficacy of stem cell products.
Stem Cell Manufacturing Market by Product, Application, Technology, Therapy, and End Use
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Stem Cell Manufacturing Market by Segments
Stem Cell Manufacturing Market by Segment
The study includes a forecast for the global stem cell manufacturing market by product, application, technology, therapy, end use, and region, as follows:
Stem Cell Manufacturing Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Adult Stem Cells
Hematopoietic
Mesenchymal
Neural
Epithelial/Skin
Others
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Very Small Embryonic Like Stem Cells
Stem Cell Manufacturing Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Regenerative Medicine
Neurology
Orthopedics
Oncology
Hematology
Cardiovascular and Myocardial Infraction
Injuries
Diabetes
Liver Disorder
Incontinence
Others
Drug Discovery And Development
Stem Cell Manufacturing Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Cell Acquisition
Bone Marrow Harvest
Umbilical Blood Cord
Apheresis
Cell Production
Therapeutic Cloning
In-vitro Fertilization
Cell Culture
Isolation
Cryopreservation
Expansion And Sub-Culture
Stem Cell Manufacturing Market by Therapy [Value ($B) Shipment Analysis from 2017 to 2028]:
Autologous
Allogenic
Stem Cell Manufacturing Market by End Use Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Stem Cell Manufacturing Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of Stem Cell Manufacturing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stem cell manufacturing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell manufacturing companies profiled in this report include.
Advanced Cell
STEMCELL
Cellular Engineering
CellGenix
PromoCell
Stem Cell Manufacturing Market Insights
Lucintel forecasts that adult stem cell will remain the largest segment over the forecast period due to the increasing usage of these cells helps in preventing embryonic damage and transplant rejection.
Pharmaceutical and biotechnology companies are expected to remain the largest segment due to the increasing clinical studies for chronic diseases and growing private investment in stem cell-based research.
North America will remain the largest region due to availability of advanced research infrastructure, increasing government initiative for advancing stem cell therapies, and presence of market leaders in the region.
Features of the Stem Cell Manufacturing Market
Market Size Estimates: Stem cell manufacturing market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: Stem cell manufacturing market size by various segments, such as by product, application, technology, therapy, end use, and region
Regional Analysis: Stem cell manufacturing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different by product, application, technology, therapy, end use, and regions for the stem cell manufacturing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell manufacturing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the stem cell manufacturing market size?
Answer: The global stem cell manufacturing market is expected to reach an estimated $6.3 billion by 2028.
Q2. What is the growth forecast for stem cell manufacturing market?
Answer: The global stem cell manufacturing market is expected to grow with a CAGR of 9.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell manufacturing market?
Answer: The major drivers for this market are increasing prevalence of genetic diseases and growing consumer awareness towards therapeutic efficacy of stem cell products.
Q4. What are the major segments for stem cell manufacturing market?
Answer: The future of the stem cell manufacturing market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes.
Q5. Who are the key stem cell manufacturing companies?
Answer: Some of the key stem cell manufacturing companies are as follows:
Advanced Cell
STEMCELL
Cellular Engineering
CellGenix
PromoCell
Q6. Which stem cell manufacturing segment will be the largest in future?
Answer: Lucintel forecasts that adult stem cell will remain the largest segment over the forecast period due to the increasing usage of these cells helps in preventing embryonic damage and transplant rejection.
Q7. In stem cell manufacturing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to availability of advanced research infrastructure, increasing government initiative for advancing stem cell therapies, and presence of market leaders in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the stem cell manufacturing market by product (adult stem cell, human embryonic stem cell, induced pluripotent stem cell, and very small embryonic like stem), application (regenerative medicine and drug discovery & development), technology (cell acquisition, cell production, cryopreservation, and expansion & sub-culture), therapy (autologous and allogenic), end use (pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to stem cell manufacturing market or related stem cell manufacturing companies, stem cell manufacturing market size, stem cell manufacturing market share, stem cell manufacturing analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Stem Cell Manufacturing Market Trends and Forecast
The future of the global stem cell manufacturing market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes. The global stem cell manufacturing market is expected to reach an estimated $6.3 billion by 2028 with a CAGR of 9.7% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases and growing consumer awareness towards therapeutic efficacy of stem cell products.
Stem Cell Manufacturing Market by Product, Application, Technology, Therapy, and End Use
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Stem Cell Manufacturing Market by Segments
Stem Cell Manufacturing Market by Segment
The study includes a forecast for the global stem cell manufacturing market by product, application, technology, therapy, end use, and region, as follows:
Stem Cell Manufacturing Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:
Adult Stem Cells
Hematopoietic
Mesenchymal
Neural
Epithelial/Skin
Others
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Very Small Embryonic Like Stem Cells
Stem Cell Manufacturing Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
Regenerative Medicine
Neurology
Orthopedics
Oncology
Hematology
Cardiovascular and Myocardial Infraction
Injuries
Diabetes
Liver Disorder
Incontinence
Others
Drug Discovery And Development
Stem Cell Manufacturing Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:
Cell Acquisition
Bone Marrow Harvest
Umbilical Blood Cord
Apheresis
Cell Production
Therapeutic Cloning
In-vitro Fertilization
Cell Culture
Isolation
Cryopreservation
Expansion And Sub-Culture
Stem Cell Manufacturing Market by Therapy [Value ($B) Shipment Analysis from 2017 to 2028]:
Autologous
Allogenic
Stem Cell Manufacturing Market by End Use Value ($B) Shipment Analysis from 2017 to 2028]:
Pharmaceutical & Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Stem Cell Manufacturing Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
North America
Europe
Asia Pacific
The Rest of the World
List of Stem Cell Manufacturing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stem cell manufacturing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell manufacturing companies profiled in this report include.
Advanced Cell
STEMCELL
Cellular Engineering
CellGenix
PromoCell
Stem Cell Manufacturing Market Insights
Lucintel forecasts that adult stem cell will remain the largest segment over the forecast period due to the increasing usage of these cells helps in preventing embryonic damage and transplant rejection.
Pharmaceutical and biotechnology companies are expected to remain the largest segment due to the increasing clinical studies for chronic diseases and growing private investment in stem cell-based research.
North America will remain the largest region due to availability of advanced research infrastructure, increasing government initiative for advancing stem cell therapies, and presence of market leaders in the region.
Features of the Stem Cell Manufacturing Market
Market Size Estimates: Stem cell manufacturing market size estimation in terms of value ($B)
Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
Segmentation Analysis: Stem cell manufacturing market size by various segments, such as by product, application, technology, therapy, end use, and region
Regional Analysis: Stem cell manufacturing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth Opportunities: Analysis on growth opportunities in different by product, application, technology, therapy, end use, and regions for the stem cell manufacturing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell manufacturing market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the stem cell manufacturing market size?
Answer: The global stem cell manufacturing market is expected to reach an estimated $6.3 billion by 2028.
Q2. What is the growth forecast for stem cell manufacturing market?
Answer: The global stem cell manufacturing market is expected to grow with a CAGR of 9.7% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the stem cell manufacturing market?
Answer: The major drivers for this market are increasing prevalence of genetic diseases and growing consumer awareness towards therapeutic efficacy of stem cell products.
Q4. What are the major segments for stem cell manufacturing market?
Answer: The future of the stem cell manufacturing market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes.
Q5. Who are the key stem cell manufacturing companies?
Answer: Some of the key stem cell manufacturing companies are as follows:
Advanced Cell
STEMCELL
Cellular Engineering
CellGenix
PromoCell
Q6. Which stem cell manufacturing segment will be the largest in future?
Answer: Lucintel forecasts that adult stem cell will remain the largest segment over the forecast period due to the increasing usage of these cells helps in preventing embryonic damage and transplant rejection.
Q7. In stem cell manufacturing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to availability of advanced research infrastructure, increasing government initiative for advancing stem cell therapies, and presence of market leaders in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the stem cell manufacturing market by product (adult stem cell, human embryonic stem cell, induced pluripotent stem cell, and very small embryonic like stem), application (regenerative medicine and drug discovery & development), technology (cell acquisition, cell production, cryopreservation, and expansion & sub-culture), therapy (autologous and allogenic), end use (pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?
For any questions related to stem cell manufacturing market or related stem cell manufacturing companies, stem cell manufacturing market size, stem cell manufacturing market share, stem cell manufacturing analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL STEM CELL MANUFACTURING MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Stem Cell Manufacturing Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Stem Cell Manufacturing Market by Product
3.3.1: Adult Stem Cells
3.3.1.1: Hematopoietic
3.3.1.2: Mesenchymal
3.3.1.3: Neural
3.3.1.4: Epithelial/Skin
3.3.1.5: Others
3.3.2: Human Embryonic Stem Cells
3.3.3: Induced Pluripotent Stem Cells
3.3.4: Very Small Embryonic Like Stem Cells
3.4: Global Stem Cell Manufacturing Market by Application
3.4.1: Regenerative Medicine
3.4.1.1: Neurology
3.4.1.2: Orthopedics
3.4.1.3: Oncology
3.4.1.4: Hematology
3.4.1.5: Cardiovascular and Myocardial Infraction
3.4.1.6: Injuries
3.4.1.7: Diabetes
3.4.1.8: Liver Disorder
3.4.1.9: Incontinence
3.4.1.10: Others
3.4.2: Drug Discovery and Development
3.5: Global Stem Cell Manufacturing Market by Technology
3.5.1: Cell Acquisition
3.5.1.1: Bone Marrow Harvest
3.5.1.2: Umbilical Blood Cord
3.5.1.3: Apheresis
3.5.2: Cell Production
3.5.2.1: Therapeutic Cloning
3.5.2.2: In-vitro Fertilization
3.5.2.3: Cell Culture
3.5.2.4: Isolation
3.5.3: Cryopreservation
3.5.4: Expansion and Sub-Culture
3.6: Global Stem Cell Manufacturing Market by Therapy
3.6.1: Autologous
3.6.2: Allogenic
3.7: Global Stem Cell Manufacturing Market by End Use
3.7.1: Pharmaceutical & Biotechnology Companies
3.7.2: Hospitals & Cell Banks
3.7.3: Academic & Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Stem Cell Manufacturing Market by Region
4.2: North American Stem Cell Manufacturing Market
4.2.1: North American Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.2.2: North American Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.3: European Stem Cell Manufacturing Market
4.3.1: European Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.3.2: European Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.4: APAC Stem Cell Manufacturing Market
4.4.1: APAC Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.4.2: APAC Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.5: ROW Stem Cell Manufacturing Market
4.5.1: ROW Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.5.2: ROW Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Stem Cell Manufacturing Market by Product
6.1.2: Growth Opportunities for the Global Stem Cell Manufacturing Market by Application
6.1.3: Growth Opportunities for the Global Stem Cell Manufacturing Market by Technology
6.1.4: Growth Opportunities for the Global Stem Cell Manufacturing Market by Therapy
6.1.5: Growth Opportunities for the Global Stem Cell Manufacturing Market by End Use
6.1.6: Growth Opportunities for the Global Stem Cell Manufacturing Market by Region
6.2: Emerging Trends in the Global Stem Cell Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Stem Cell Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Advanced Cell
7.2: STEMCELL
7.3: Cellular Engineering
7.4: CellGenix
7.5: PromoCell
2. GLOBAL STEM CELL MANUFACTURING MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Stem Cell Manufacturing Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Stem Cell Manufacturing Market by Product
3.3.1: Adult Stem Cells
3.3.1.1: Hematopoietic
3.3.1.2: Mesenchymal
3.3.1.3: Neural
3.3.1.4: Epithelial/Skin
3.3.1.5: Others
3.3.2: Human Embryonic Stem Cells
3.3.3: Induced Pluripotent Stem Cells
3.3.4: Very Small Embryonic Like Stem Cells
3.4: Global Stem Cell Manufacturing Market by Application
3.4.1: Regenerative Medicine
3.4.1.1: Neurology
3.4.1.2: Orthopedics
3.4.1.3: Oncology
3.4.1.4: Hematology
3.4.1.5: Cardiovascular and Myocardial Infraction
3.4.1.6: Injuries
3.4.1.7: Diabetes
3.4.1.8: Liver Disorder
3.4.1.9: Incontinence
3.4.1.10: Others
3.4.2: Drug Discovery and Development
3.5: Global Stem Cell Manufacturing Market by Technology
3.5.1: Cell Acquisition
3.5.1.1: Bone Marrow Harvest
3.5.1.2: Umbilical Blood Cord
3.5.1.3: Apheresis
3.5.2: Cell Production
3.5.2.1: Therapeutic Cloning
3.5.2.2: In-vitro Fertilization
3.5.2.3: Cell Culture
3.5.2.4: Isolation
3.5.3: Cryopreservation
3.5.4: Expansion and Sub-Culture
3.6: Global Stem Cell Manufacturing Market by Therapy
3.6.1: Autologous
3.6.2: Allogenic
3.7: Global Stem Cell Manufacturing Market by End Use
3.7.1: Pharmaceutical & Biotechnology Companies
3.7.2: Hospitals & Cell Banks
3.7.3: Academic & Research Institutes
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Stem Cell Manufacturing Market by Region
4.2: North American Stem Cell Manufacturing Market
4.2.1: North American Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.2.2: North American Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.3: European Stem Cell Manufacturing Market
4.3.1: European Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.3.2: European Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.4: APAC Stem Cell Manufacturing Market
4.4.1: APAC Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.4.2: APAC Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
4.5: ROW Stem Cell Manufacturing Market
4.5.1: ROW Stem Cell Manufacturing Market by Product: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, and Very Small Embryonic Like Stem
4.5.2: ROW Stem Cell Manufacturing Market by End Use: Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks, and Academic & Research Institutes
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Stem Cell Manufacturing Market by Product
6.1.2: Growth Opportunities for the Global Stem Cell Manufacturing Market by Application
6.1.3: Growth Opportunities for the Global Stem Cell Manufacturing Market by Technology
6.1.4: Growth Opportunities for the Global Stem Cell Manufacturing Market by Therapy
6.1.5: Growth Opportunities for the Global Stem Cell Manufacturing Market by End Use
6.1.6: Growth Opportunities for the Global Stem Cell Manufacturing Market by Region
6.2: Emerging Trends in the Global Stem Cell Manufacturing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Stem Cell Manufacturing Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Manufacturing Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Advanced Cell
7.2: STEMCELL
7.3: Cellular Engineering
7.4: CellGenix
7.5: PromoCell
